Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294308001> ?p ?o ?g. }
- W4294308001 endingPage "9910" @default.
- W4294308001 startingPage "9910" @default.
- W4294308001 abstract "Regardless of the significant improvements in treatment of melanoma, the majority of patients develop resistance whose mechanisms are still not completely understood. Hence, we generated and characterized two melanoma-derived cell lines, primary WM793B and metastatic A375M, with acquired resistance to the RAF inhibitor vemurafenib. The morphology of the resistant primary WM793B melanoma cells showed EMT-like features and exhibited a hybrid phenotype with both epithelial and mesenchymal characteristics. Surprisingly, the vemurafenib-resistant melanoma cells showed a decreased migration ability but also displayed a tendency to collective migration. Signaling pathway analysis revealed the reactivation of MAPK and the activation of the PI3K/AKT pathway depending on the vemurafenib-resistant cell line. The acquired resistance to vemurafenib caused resistance to chemotherapy in primary WM793B melanoma cells. Furthermore, the cell-cycle analysis and altered levels of cell-cycle regulators revealed that resistant cells likely transiently enter into cell cycle arrest at the G0/G1 phase and gain slow-cycling cell features. A decreased level of NME1 and NME2 metastasis suppressor proteins were found in WM793B-resistant primary melanoma, which is possibly the result of vemurafenib-acquired resistance and is one of the causes of increased PI3K/AKT signaling. Further studies are needed to reveal the vemurafenib-dependent negative regulators of NME proteins, their role in PI3K/AKT signaling, and their influence on vemurafenib-resistant melanoma cell characteristics." @default.
- W4294308001 created "2022-09-02" @default.
- W4294308001 creator A5004625005 @default.
- W4294308001 creator A5035333815 @default.
- W4294308001 creator A5041630328 @default.
- W4294308001 creator A5047779520 @default.
- W4294308001 creator A5050415186 @default.
- W4294308001 creator A5062649792 @default.
- W4294308001 creator A5067438060 @default.
- W4294308001 creator A5074029698 @default.
- W4294308001 creator A5079256131 @default.
- W4294308001 date "2022-08-31" @default.
- W4294308001 modified "2023-10-14" @default.
- W4294308001 title "Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance" @default.
- W4294308001 cites W1497663772 @default.
- W4294308001 cites W1497707271 @default.
- W4294308001 cites W1952485984 @default.
- W4294308001 cites W1969621613 @default.
- W4294308001 cites W1994487573 @default.
- W4294308001 cites W1995103178 @default.
- W4294308001 cites W2007599495 @default.
- W4294308001 cites W2008878539 @default.
- W4294308001 cites W2016360721 @default.
- W4294308001 cites W2034822895 @default.
- W4294308001 cites W2041844234 @default.
- W4294308001 cites W2048182509 @default.
- W4294308001 cites W2053195947 @default.
- W4294308001 cites W2058390096 @default.
- W4294308001 cites W2076583198 @default.
- W4294308001 cites W2087367170 @default.
- W4294308001 cites W2111853926 @default.
- W4294308001 cites W2112270062 @default.
- W4294308001 cites W2128542677 @default.
- W4294308001 cites W2129124145 @default.
- W4294308001 cites W2137005750 @default.
- W4294308001 cites W2149271063 @default.
- W4294308001 cites W2149796346 @default.
- W4294308001 cites W2155554726 @default.
- W4294308001 cites W2161951166 @default.
- W4294308001 cites W2168711434 @default.
- W4294308001 cites W2171215312 @default.
- W4294308001 cites W2276450128 @default.
- W4294308001 cites W2416824063 @default.
- W4294308001 cites W2520301766 @default.
- W4294308001 cites W2558772117 @default.
- W4294308001 cites W2568018505 @default.
- W4294308001 cites W2579450356 @default.
- W4294308001 cites W2580878435 @default.
- W4294308001 cites W2621895366 @default.
- W4294308001 cites W2766812143 @default.
- W4294308001 cites W2786843484 @default.
- W4294308001 cites W2791766571 @default.
- W4294308001 cites W2795195475 @default.
- W4294308001 cites W2799898775 @default.
- W4294308001 cites W2806295244 @default.
- W4294308001 cites W2895217890 @default.
- W4294308001 cites W2902153433 @default.
- W4294308001 cites W2912456393 @default.
- W4294308001 cites W2921712342 @default.
- W4294308001 cites W292268398 @default.
- W4294308001 cites W2945039444 @default.
- W4294308001 cites W2970774940 @default.
- W4294308001 cites W2972966486 @default.
- W4294308001 cites W2978787070 @default.
- W4294308001 cites W2981395586 @default.
- W4294308001 cites W2986212729 @default.
- W4294308001 cites W2996253303 @default.
- W4294308001 cites W2996626611 @default.
- W4294308001 cites W3004648622 @default.
- W4294308001 cites W3007104302 @default.
- W4294308001 cites W3013488172 @default.
- W4294308001 cites W3013594993 @default.
- W4294308001 cites W3027970407 @default.
- W4294308001 cites W3047437275 @default.
- W4294308001 cites W3092398155 @default.
- W4294308001 cites W3092828231 @default.
- W4294308001 cites W3103583647 @default.
- W4294308001 cites W3158376581 @default.
- W4294308001 cites W3162378859 @default.
- W4294308001 cites W3206593851 @default.
- W4294308001 cites W4211233744 @default.
- W4294308001 doi "https://doi.org/10.3390/ijms23179910" @default.
- W4294308001 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36077308" @default.
- W4294308001 hasPublicationYear "2022" @default.
- W4294308001 type Work @default.
- W4294308001 citedByCount "10" @default.
- W4294308001 countsByYear W42943080012022 @default.
- W4294308001 countsByYear W42943080012023 @default.
- W4294308001 crossrefType "journal-article" @default.
- W4294308001 hasAuthorship W4294308001A5004625005 @default.
- W4294308001 hasAuthorship W4294308001A5035333815 @default.
- W4294308001 hasAuthorship W4294308001A5041630328 @default.
- W4294308001 hasAuthorship W4294308001A5047779520 @default.
- W4294308001 hasAuthorship W4294308001A5050415186 @default.
- W4294308001 hasAuthorship W4294308001A5062649792 @default.
- W4294308001 hasAuthorship W4294308001A5067438060 @default.
- W4294308001 hasAuthorship W4294308001A5074029698 @default.
- W4294308001 hasAuthorship W4294308001A5079256131 @default.